Video & Transcript Research : 'insulin'

Page 1 of 21
MN

Minnesota 2025-2026 Regular Session

House Commerce Finance and Policy Committee 3/10/26

Commerce Finance and Policy

Transcript Highlights:
  • And all insulins aren't created equal. Some insulins work better, some not so.
  • reality is being on the wrong insulin reality is being on the wrong insulin can<00:39:22.640>
  • mandate coverage of all insulins. mandate coverage of all insulins.
  • Without insulin, I would not survive. Without insulin, I would not survive.
  • protocol for insulin products. protocol for insulin products.
MN

Minnesota 2025-2026 Regular Session

House Health Finance and Policy Committee 4/15/26

Health Finance and Policy

TX

Texas 89th Regular

S/C on Disease Prevention & Women's & Children's Health Apr 17th, 2025

S/C on Disease Prevention & Women's & Children's Health

Transcript Highlights:
  • Kevin's Law granted a pharmacist the right to dispense a 30-day supply of emergency insulin and insulin-related
  • Many insulin doses are pre-packaged. This is what we're trying to fix here.
  • Many insulin doses are pre-packaged in insulin.
  • However, insulin does not come with a standard dose for everyone, and one size does not fit.
  • As a result, some prepackaged insulin exceeds a 30-day supply.
MN

Minnesota 2025-2026 Regular Session

Health Committee Meeting - 2026-04-13

Health Finance and Policy

Transcript Highlights:
  • This bill makes minor clarification by defining covered insulin.
  • Specifically, the program provides access to covered insulin and makes a series of technical updates
  • safety net program for individuals that are in need of insulin to manage diabetes.
  • > the<00:37:38.960> urgent Unlike insulin products in the urgent Unlike insulin products
  • > in<00:37:52.520> the And unlike insulin products in the And unlike insulin products in
Summary: The committee met at 1:00 p.m., confirmed a quorum, and approved the April 8, 2026 minutes. The first bill heard was House File 4712, which was laid over after the committee adopted a DE2 amendment. Representative Schultz said the bill would create a narrow additional exception to public pool limitations so highly certified swimming instructors could use certain pools for specialized infant, youth, and developmental-disability swim instruction. The only testifier, Tessa Seppelt, described ISR instruction as water-safety and drowning-prevention training for very young children and children with developmental delays, and said access to appropriate facilities is the main barrier. Members raised questions about emergency egress, public safety, and insurance coverage, and the author said he would follow up on those concerns. The committee then took up House File 4801, a bill by Representative Nadeau aimed at health care program integrity. He said it would align commercial and Medicaid partners to reduce waste, fraud, and abuse by changing prior authorization and retrospective review processes, improving data sharing on suspected fraud, addressing conflicting or duplicative services, allowing managed care organizations to verify provider credentials, and making risk corridors in MCO contracts permanent. The Minnesota Council of Health Plans supported the bill, saying it would help detect fraud and improve coordination, while the Minnesota chapter of the American Academy of Pediatrics opposed it, arguing that expanded prior authorization would delay care, increase physician burden, and harm children with chronic conditions. Members debated patient safety, fraud detection, and whether the bill would undermine recent prior-authorization reforms. The bill was laid over. House File 3756, a technical update to the insulin safety net program, was also laid over. Representative Backer said the bill clarifies that a hospital-use intravenous insulin product is not part of the program because it is sold only to health care institutions and infused by practitioners, not dispensed to patients for self-use. The Board of Pharmacy testified that the language was drafted to avoid affecting future legitimate uses, and members asked whether the definition could limit new uses if treatments change. The committee then began House File 4860, but the transcript cuts off before the bill’s presentation is completed.
OK

Oklahoma 2026 Regular Session

Appropriations REVISED Feb 18th, 2026 at 10:00 am

Appropriations

Transcript Highlights:
  • Senate Bill 1344 creates the insulin accessibility program at the health department to increase patient
  • access to affordable insulin and encourage marketplace competition.
MN

Minnesota 2025-2026 Regular Session

Health Committee Meeting - 2026-03-25

Health Finance and Policy

Transcript Highlights:
  • Um, since I've been on these medications, I have no longer taken injectable insulin, which I know saves
  • Um, since I've been on these medications, I have no longer taken injectable insulin, which I know saves
  • doctor and all those things that we heard about, I don't have to reiterate them, are true. injectable insulin
  • , which I know saves injectable insulin, which I know saves my<01:09:54.960> insurance<01:09:55.400
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Financial Services Jun 21st, 2026 at 10:30 am

Joint Committee on Financial Services

Transcript Highlights:
  • Insulin needs can be unpredictable.
  • Insulin needs can be unpredictable, insulin can spoil, bottles can break.
  • He requires insulin for the rest of his life. Insulin is a life-sustaining hormone.
  • He ran out of insulin.
  • It costs $3 to make a vial of insulin.
Keywords: 995, all
Summary: The Joint Committee on Financial Services held a hearing with Chair Jamie Murphy and Senate co-chair Senator Feeney presiding. Members asked witnesses to keep testimony to three minutes and noted that written testimony could still be submitted. The committee heard testimony on several health insurance and pharmacy-related bills, including a proposal to allow controlled prescriptions to be transferred between pharmacies within the same chain, legislation affecting health savings account (HSA)-compatible plans and future insurance mandates, a bill on small business health insurance incentives, and H. 1212 on emergency insulin access. Several parents and patients testified in support of emergency insulin access, describing severe diabetes emergencies, diabetic ketoacidosis, prescription delays, and the need for pharmacists to dispense insulin in urgent situations when doctors or insurers are unavailable. A parent also described the burden of repeatedly obtaining new prescriptions for ADHD medication when pharmacies are out of stock. Witnesses supporting the HSA bill argued that state coverage mandates can unintentionally disqualify HSA-qualified plans and that the bill would preserve tax advantages for enrollees while avoiding repeated legislative fixes. A representative of the Retailers Association supported the small business health insurance incentives bill, saying it could help retain small employers in the merged market by allowing carriers to offer financial incentives tied to cooperative purchasing and utilization efforts. One witness, Kathleen Demarest, testified against a co-pay assistance restriction, saying a state rule had unexpectedly cut off her drug assistance before a generic was actually available, leaving her with very high out-of-pocket costs. Committee members asked a few clarifying questions about HSAs, insulin dispensing, and school support for diabetes care. After all scheduled witnesses had testified and no additional testimony was offered, the committee voted to close the hearing.
FL

Florida 2026 Regular Session

Children, Families, and Elder Affairs Mar 19th, 2025

Children, Families, and Elder Affairs

Transcript Highlights:
  • scale insulin therapy as a permissible practice for direct support professionals and relatives.
  • It adds subcutaneous administration of insulin and epinephrine by self-administration devices to the
  • insulin therapy as a permissible practice for direct support professionals and relatives.
  • It adds subcutaneous administration of insulin and epinephrine by self-administration devices to the
  • He started taking his own insulin at age 10.
Summary: The committee met with a quorum present and took up several bills. SB 894, relating to faith-based content in batterers’ intervention programs, was explained as allowing certified programs to offer voluntary faith-based components alongside existing models. Members raised questions about how faith would be defined, whether participation would be optional, and how all faiths would be included. An amendment was adopted clarifying that faith-based activities may be offered but not required and removing language directing DCF to repeal a rule. After supportive testimony from faith-based advocates and some debate, the committee reported the bill favorably, with Senators Harrell and Garcia later recording affirmative votes. The committee then considered SB 1240 on substance abuse and mental health care, which would assign state oversight of the 988 Lifeline, remove the annual needs assessment barrier for medication-assisted treatment licensing, and require annual continuing education for forensic evaluators. An amendment with technical conforming changes and two substantive clarifications was adopted. Members expressed support for expanded access to behavioral health services, and the bill was reported favorably. Later, the chair presented SB 1736, which would allow direct support professionals and relatives to administer insulin in group home settings for individuals with developmental disabilities. After an amendment clarifying sliding scale insulin and related medication administration, the committee heard testimony from family advocates describing how the bill would prevent unnecessary institutionalization and reduce costs. The bill was reported favorably. The committee also passed SB 1286, which clarifies that allowing children to engage in unsupervised activities such as biking or playing outside does not by itself constitute neglect unless reckless or dangerous. After brief support testimony, that bill was also reported favorably, and the meeting adjourned.
MN

Minnesota 2025-2026 Regular Session

Committee on Commerce and Consumer Protection - 03/05/26

Commerce and Consumer Protection

Transcript Highlights:
  • coverage for prescription insulin. coverage for prescription insulin.
  • :59:54.960> insulin.
  • If I cannot fill my insulin care.
  • high cost of insulin.
  • the high cost of insulin.
Keywords: 1187, senate, all
TX

Texas 89th Regular

Health and Human Services May 23rd, 2025

Health & Human Services

Transcript Highlights:
  • This allowed people with medical needs to access insulin during times like holidays when primary care
  • Senator Sparks: Today, many insulin doses are packaged into insulin pens or insulin cartridges.
  • House Bill 632 allows pharmacists to provide a supply of insulin that exceeds Senator Sparks: 30 days
  • And I mean as you say, insulin is a life-saving drug. It seems like a common sense bill.
  • So like we mentioned, insulin is a life-saving medication.
Bills: HB50
OK

Oklahoma 2026 Regular Session

Senate Legislative Session Mar 24th, 2026 at 01:30 pm

Oklahoma Senate Floor Meeting

Transcript Highlights:
  • per pack of prefilled insulin pens.
  • Insulin will not go down.
  • under the promise that anyone who needed insulin would have affordable insulin available.
  • Folks with type one diabetes rely on not only fast-acting biosimilar insulin but also long-acting insulin
  • This won't fix the price of insulin.
TX
Transcript Highlights:
  • Today, many insulin doses are packaged into insulin pens or insulin cartridges.
  • However, insulin does not come with a standard dose for everyone, and one dose does not fit all.
  • Dosed, packed packs of insulin and related supplies exceed a 30-day supply.
  • House Bill 632 allows pharmacists to provide a supply of insulin that exceeds 30 days if that is the
  • Right, and I mean, as you say, insulin is a life-saving drug. It’s a common-sense bill.
Bills: HB50
NH
Transcript Highlights:
  • insulin can very used to be insulin insulin can very effectively<00:42:18.040> control<00:42:
  • , who were needing insulin.
  • So there is a whole class of long-acting insulin, bio- or insulin-secretor extended release.
  • bio or insulin secretor extended insulin bio or insulin secretor extended release<01:18:57.199> yeah
  • , or is it your insulin?
Keywords: 928, house, all
Summary: The committee held a public hearing on House Bill 552, which would remove the “full-time student” requirement for children ages 19 to 25 covered under the state retiree health insurance plan. The prime sponsor said the change would align retiree coverage with state employee and ACA plans, would not cost taxpayers because retirees pay the premiums, and could even reduce administrative burden and possibly state costs. The chair noted the bill simply removes the words “if full-time student” from statute and said the proposal affects very few retirees and has no cost to the state. No opposition was presented, and the chair closed the hearing on HB 552 after no further testimony. The committee then opened a public hearing on House Bill 648, which would require commercial insurance coverage for glucose monitoring devices and supplies for people with diabetes. The prime sponsor, a retired dietitian and diabetes educator, gave extensive testimony describing diabetes as common, costly, and serious, and argued that continuous glucose monitoring is important for managing type 2 and gestational diabetes, preventing hypoglycemia, and improving safety and decision-making. She said CGMs can alert users to dangerous blood sugar changes, help people understand how food, activity, and medication affect glucose, and save lives while offering a strong return on investment. During questions, a committee member asked whether the bill should specify that the monitoring be tied to prescribed treatment, and the sponsor agreed that adding “prescribed” would be appropriate. The member also asked about the proper threshold for coverage and whether the bill should be tied to fasting-test diagnosis; the sponsor responded that A1C is only one measure of control and does not show daily fluctuations, and said she was not prepared to recommend a specific threshold but could provide clinical guidelines later. No vote was taken during the hearing, and the sponsor indicated support for the bill’s general approach to broader CGM access.
NH
Transcript Highlights:
  • disease the newer non-insulin disease the newer non-insulin medications<00:31:55.399> are
  • <00:33:01.200> or determine the dose of their insulin or determine the dose of their insulin
  • <00:44:09.720> and is already somebody taking insulin and is already somebody taking insulin
  • so Med foran is considered a non-insulin so Med foran is considered a non-insulin bill<00:49:03.200
  • I mean, got multiple visits and all that sort of thing for anybody with an insulin, uh, not an insulin
Keywords: 928, house, all
Summary: The subcommittee first reviewed its schedule, noting that 13 bills were being executed the next day and that additional subcommittee work would be scheduled around Town Meeting Day and the following session days. The chair explained that the committee would not meet on Town Meeting Day, would handle the remaining bills on the next available subcommittee day, and would continue any unfinished items later in the month. The committee then took up House Bill 774, which concerned Medicare-related coverage issues. Members discussed the bill’s purpose and the differences between Medicare standard and Medicare Advantage, with one member saying the proposal was informative but did not offer a workable solution. The committee also moved to inexpedient to legislate on House Bill 185, and the motion passed on a 6-0 vote. House Bill 241, relating to alternatives to opioids, was retained for further work. Members said the bill raised concerns about insurers effectively practicing medicine and about the lack of evidence on the efficacy of some alternative treatments, while also noting that chiropractic coverage mandates already exist in statute. The committee voted to retain the bill, with the motion passing 6-0. The most extended discussion was on House Bill 648, which would expand insurance coverage for glucose monitoring. Testimony and committee comments focused on whether coverage should be tied to insulin use or instead to a physician’s medical judgment, the role of continuous glucose monitoring for people with type 2 diabetes who are not on insulin, and the potential cost impact. An insurance department fiscal analyst said the original $22-per-member estimate was based on the unamended bill and that the amended version would require updated analysis; members agreed to retain the bill to narrow the eligible population and revisit the language later.
CA

California 2025-2026 Regular Session

Assembly Health Committee Jul 15th, 2025

Transcript Highlights:
  • for insulin treatments unless health plans have at least one insulin for each drug type covered, similar
  • Insulin is not optional.
  • Insulin is not optional.
  • Insulin is not optional. I therefore ask for your aye vote to cap insulin co-pays at $35 a month.
  • I don't really understand why insulin is so expensive.
Summary: The Assembly Health Committee heard several bills focused on health care access, oversight, and affordability. The first major item was SB 306 by Senator Becker, a prior authorization reform bill. Becker and supporters, including the California Medical Association and California Hospital Association, argued that prior authorization delays care, adds administrative burden, and can lead to serious patient harm. The bill was substantially amended late in the process to have DMHC and CDI identify services and drugs to exempt from prior authorization based on utilization data, with safeguards for fraud, waste, abuse, and patient safety. Health plans and insurers opposed the measure as written, saying prior authorization remains an important utilization-management tool and raising concerns about the 90% threshold, drug inclusion, and how modifications are counted. The committee also heard SB 35 by Senator Umberg, which would let cities or counties inspect unlicensed sober living homes if DHCS does not act promptly on complaints. Supporters said the bill would address weak enforcement and protect residents, while one behavioral health directors group opposed it unless amended. Members generally supported the measure, citing problems with unlicensed facilities and the need for local enforcement backup. The committee then heard SB 62, which would codify California’s updated essential health benefits benchmark if approved by the federal government. Senator Wiener said the package would add hearing aids, durable medical equipment, and infertility treatment including IVF, acknowledging that premiums could rise but arguing the benefits were worth it. Health Access California and other advocates supported the bill, while the California Family Council opposed it. The committee also took up SB 596 by Senator Menjivar, which would tighten the rules for hospitals claiming an on-call list as a defense to nurse staffing ratio penalties. Supporters, including nurses and SEIU, said hospitals have used vague or ineffective on-call practices to avoid accountability and that the bill would improve enforcement and patient safety. Hospital groups opposed it, arguing that staffing is highly dynamic, that hospitals need flexibility to manage acuity and emergencies, and that the bill could increase costs and interfere with collective bargaining arrangements. Finally, the committee heard SB 40 by Senator Wiener, the Insulin Affordability Act, which would cap insulin copays at $35 for a 30-day supply and restrict step therapy unless a plan covers at least one insulin in each drug type. Supporters, including physicians, diabetes advocates, nurses, students, and patient groups, said insulin is life-saving and too often unaffordable, forcing patients to ration or choose between medication and basic needs. There was no formal opposition testimony, though one member questioned why insulin remains so expensive. The committee also began discussion of SB 363, but the transcript cuts off before that bill’s full presentation or any action on the measures. No votes are recorded in the portion provided, and several bills were noted as consent items earlier in the hearing.
CA
Transcript Highlights:
  • To begin, do you have any kind of timeline you can share on the insulin?
  • Yeah, a couple of questions on the insulin product.
  • In the meantime, Californians are struggling to afford their insulin.
  • Twenty-six other states have already passed insulin copay caps.
  • Yet again, to cap insulin co-pays at $35 for California Rx Insulin.
Keywords: 988, house, all
FL

Florida 2025 Regular Session

March 18, 2025 - 09:00 AM

Transcript Highlights:
  • Relating to insulin administration by direct support professionals.
  • Is the administration of the insulin through an EpiPen? You're recognized.
  • provider may supervise self-administration of an insulin pen.
  • But to give him the insulin shot, they can't.
  • When we were told that he would need an insulin shot... They can't.
Summary: The committee met with a quorum present and heard six bills, all of which were reported favorably. HB 1567, relating to insulin administration by direct support professionals, was amended to clarify the type of insulin that may be administered and to allow supervision of self-administration of an insulin pen. Supporters described the bill as a way to keep people with developmental disabilities in group homes rather than forcing institutional placement; the amendment and bill both passed unanimously, 17-0. PCS for HB 1103, on services for persons with disabilities, would expand the APD managed care pilot statewide in phases, require more transparency on waitlist data, create a statewide family care council, and address transition services for young adults leaving foster care. Testimony was mixed: supporters emphasized the long APD waitlist and the need for a voluntary option, while some witnesses and members raised concerns about the accelerated rollout, limited data, and preserving consumer-directed care. The committee adopted the bill 17-0. CS for HB 127, on exceptional student education, would create micro-credentials and coordinate with the Florida Center for Students with Unique Abilities and OSHA to support students with disabilities transitioning to work; it passed 17-0 after testimony from a parent and advocates. HB 989, concerning licensure of family foster homes, was amended to streamline license transfers for foster parents moving within Florida while maintaining oversight and directing DCF rulemaking. A teacher and other supporters said the bill would reduce bureaucracy and help children remain in stable homes; it passed 17-0. PCS for HB 1091, on substance abuse and mental health care, updates processes related to the 988 crisis line, methadone treatment needs assessments, and forensic evaluators, and adds data/reporting requirements for DCF managing entities. After one amendment and testimony from supporters and one opponent, it passed 16-0. Finally, HB 633, on behavioral health managing entities, was amended and then approved 17-0; it requires more structured data and reporting from managing entities to increase accountability and transparency in the behavioral health system.
FL
Transcript Highlights:
  • SB 1736 ADDRESSES A CRITICAL GAP IN CARE BY PROVIDING DIRECT SUPPORT PROFESSIONALS TO ADMINISTER INSULIN
  • HOME TO RECEIVE CARE BECAUSE THEY HAVE DIABETES OR SEPARATE ISSUES WHERE THEY CAN'T DRAW THEIR OWN INSULIN
  • OUR ENDOCRINOLOGIST STATED HIS DIABETES WHICH HE HAS HAS DEVELOPED WHERE HE NEEDS TO HAVE A SMALL INSULIN
  • HE STARTED TAKING HIS OWN INSULIN AT AGE 10.
  • AND TO HAVE SOMEONE GO INTO A NURSING HOME BECAUSE THEY NEED AN INSULIN SHOT TWICE A DAY OR THREE TIMES
Keywords: 999, senate, all